Positional effects of presenilin-1 mutations on tau phosphorylation in cortical plaques

被引:31
作者
Shepherd, CE
Gregory, GC
Vickers, JC
Brooks, WS
Kwok, JBJ
Schofield, PR
Kril, JJ
Halliday, GM
机构
[1] Prince Wales Med Res Inst, Randwick, NSW 2031, Australia
[2] Univ Sydney, Concord Hosp, Ctr Educ & Res Ageing, Concord 2139, Australia
[3] Univ New S Wales, Sydney, NSW 2052, Australia
[4] Univ Tasmania, Discipline Pathol, Hobart, Tas 7000, Australia
[5] Garvan Inst Med Res, Sydney, NSW 2010, Australia
基金
英国医学研究理事会;
关键词
Alzheimer's disease; presenilin; tau; phosphorylation; cotton wool plaques;
D O I
10.1016/j.nbd.2003.10.008
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Mutations in presenilin-1 (PS-1) account for the majority of familial Alzheimer's disease (AD). While increasing Abeta42 is one mechanism whereby PS-1 mutations are thought to exert their pathogenic effect, little is known about the role of tau in PS-1 AD. This study compares staining (AT8 and tau-2), morphology and quantity of tau-immunoreactive cortical plaques in six PS-1 and five sporadic AD cases. The densities of tau-positive plaques differentiated PS-1 from sporadic AD cases. All PS-1 cases demonstrated a greater than 6-fold increase in tau-2-positive plaques. In PS-1 cases with mutations in exons 5 and 6, there was an increase in classical AD plaques containing hyperphosphorylated tau (AT8- and tau 2-positive). However, cases with exon 8 and 9 mutations had numerous cotton wool plaques containing non hyperphosphorylated tau (tau-2-positive, AT8-negative). These findings suggest that PS-1 mutations increase tau deposition while mutation-specific cellular responses determine phosphorylation events and may influence cell death mechanisms. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:115 / 119
页数:5
相关论文
共 30 条
[1]   Consensus recommendations for the postmortem diagnosis of Alzheimer's disease [J].
Ball, M ;
Braak, H ;
Coleman, P ;
Dickson, D ;
Duyckaerts, C ;
Gambetti, P ;
Hansen, L ;
Hyman, B ;
Jellinger, K ;
Markesbery, W ;
Perl, D ;
Powers, J ;
Price, J ;
Trojanowski, JQ ;
Wisniewski, H ;
Phelps, C ;
Khachaturian, Z .
NEUROBIOLOGY OF AGING, 1997, 18 (04) :S1-S2
[2]   ABNORMAL PHOSPHORYLATION OF TAU-PRECEDES UBIQUITINATION IN NEUROFIBRILLARY PATHOLOGY OF ALZHEIMER-DISEASE [J].
BANCHER, C ;
GRUNDKEIQBAL, I ;
IQBAL, K ;
FRIED, VA ;
SMITH, HT ;
WISNIEWSKI, HM .
BRAIN RESEARCH, 1991, 539 (01) :11-18
[3]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[4]  
Broe M, 2001, ACTA NEUROPATHOL, V101, P616
[5]   Alzheimer's disease with spastic paraparesis and 'cotton wool' plaques: two pedigrees with PS-1 exon 9 deletions [J].
Brooks, WS ;
Kwok, JBJ ;
Kril, JJ ;
Broe, GA ;
Blumbergs, PC ;
Tannenberg, AE ;
Lamont, PJ ;
Hedges, P ;
Schofield, PR .
BRAIN, 2003, 126 :783-791
[6]  
Buée L, 1999, BRAIN PATHOL, V9, P681
[7]  
Canu N, 1998, J NEUROSCI, V18, P7061
[8]   A transcriptively active complex of APP with Fe65 and histone acetyltransferase Tip60 [J].
Cao, XW ;
Südhof, TC .
SCIENCE, 2001, 293 (5527) :115-120
[9]   The presenilin 1 ΔE9 mutation gives enhanced basal phospholipase C activity and a resultant increase in intracellular calcium concentrations [J].
Cedazo-Mínguez, A ;
Popescu, BO ;
Ankarcrona, M ;
Nishimura, T ;
Cowburn, RF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (39) :36646-36655
[10]   Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice [J].
Citron, M ;
Westaway, D ;
Xia, WM ;
Carlson, G ;
Diehl, T ;
Levesque, G ;
JohnsonWood, K ;
Lee, M ;
Seubert, P ;
Davis, A ;
Kholodenko, D ;
Motter, R ;
Sherrington, R ;
Perry, B ;
Yao, H ;
Strome, R ;
Lieberburg, I ;
Rommens, J ;
Kim, S ;
Schenk, D ;
Fraser, P ;
Hyslop, PS ;
Selkoe, DJ .
NATURE MEDICINE, 1997, 3 (01) :67-72